drugset / Trial / NCT04613869

The Effect of Esketamine on Patients Undergoing Tumor Surgery

NCT04613869

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Although the acute and chronic postoperative pain of surgical patients has gradually been paid attention to, it has not yet been better resolved.and, the incidence of anxiety and depression in cancer patients is constantly increasing,The new analgesic anesthetic esketamine hydrochloride was launched in China last year,however, in the domestic and foreign literature, there are still few reports of esketamine hydrochloride in postoperative analgesia, and most of them are retrospective and small samples.This study aims to investigate whether esketamine has advantages over traditional opioids in terms of postoperative analgesia, anxiety and depression in cancer patients.

Timeline

Start
2020-08-15
Primary completion
2021-08-15
Completion
2021-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 22.5 mg Intravenous
Subject Esketamine Other / unclassified 45 mg Intravenous
Background Hydromorphone Other / unclassified 6 mg

Indications

No indication recorded.